Back to 2017 Annual Meeting Program

Background: Only a few studies have reported on the impact of anatomical/technical factors on clinical outcomes of carotid artery stenting (CAS). This study will analyze the effect of these factors on perioperative stroke/death after CAS.
Population and Methods: This is a retrospective analysis of prospectively collected data on 456 CAS patients. A logistic regression analysis was used to determine the impact of anatomical factors (lesion length, location, severity, calcification, and arch type) and technical factors (stent type, number, diameter, and length; filter type, filter insertion to recovery time, and pre- and post-stent PTA) on perioperative stroke, death, and myocardial infarction (MI;major adverse events [MAE]).
Results: The MAE and stroke rates for the whole series were 4.7% and 2.2%. The stroke rate for asymptomatic patients was 0.46% (p=0.01). The MAE rates for patients with transient ischemic attacks (TIA) were 7% versus 3.2% for other indications (p=0.077). The stroke rates for calcific lesions were 6.3% versus 1.2% for non-calcific lesions (p=0.046). There were no significant differences in stroke and MAE rates in regards to other anatomical features.
The stroke rate for patients with dilatation prior to filter insertion with pre-stent and/or post-stent PTA was 9.1% versus 1.8% for patients without (p=0.07;) and 2.6% for patients with post-stenting dilatation versus 0% for patients without (p=0.36). MAE rates for patients with post-stenting dilatation were 5.6% versus 0% for patients without (p=0.0536). MAE rates for patients with ACCUNET filters were 1.9% versus 6.7% for other filters (p=0.029). There were no significant differences between stroke and MAE rates in regards to stent type, number, diameter, length of stent, and time from filter insertion to recovery time.
A regression analysis showed that the odds ratio for stroke was 0.1 (p=0.031) for asymptomatic indications, 13.7 (p=0.014) for TIA indications, 6.1 (p=0.0303) for dilatation performed prior to filter insertion, and 1.7 (p=0.4413) for PTA performed prior to stenting. It also showed that the MAE odds ratio was 0.46 (p=0.0858) for asymptomatic indications, 2.1 (p=0.35) for pre-dilatations performed prior to filter insertion, and 2.2 (p=0.22) for post-stent dilatations. A multivariate analysis showed that patients with TIA indications had an odds ratio of stroke of 15.26 (p=0.0113); and patients with dilations performed prior to filter insertion with pre-stent and/or post-stent PTA had an odds ratio of 7.98 (p=0.0193). The MAE odds ratio for ACCUNET versus other filters was 0.27 (p=0.0389, Tables).
Conclusions: PTA prior to filter insertion had higher stroke rates and post-stenting PTA was associated with higher MAE rates. The ACCUNET filter was associated with lower stroke and MAE rates. There was no correlation between other anatomical/technical variables.
Table
PTA Combination and Perioperative Stroke and Major Adverse Events

Dilation	Stroke No. (%)	MAE No. (%)
None	0/26	0/26
Pre-EPD only	0/1	0/1
Pre-stent only	0/39	0/39
Post-stent only	2/130 (1.5)	6/130 (4.6)
Pre-EPD & pre-stent	0/2	0/2
Pre-EPD & post-stent	1/8 (12.5)	1/8 (12.5)
Pre-stent & post-stent	5/192 (2.6)	11/192 (5.7)
Pre-EPD, pre-stent & post- stent	1/11 (9.1)	1/11 (9.1)

Table
Logistic Regression Analysis

Univariate - Early Stroke
Variable		OR		95% CI	p-value
Age		1.03		(0.96,1.11)	0.4058
Gender (Male vs Female)		0.86		(0.23,3.24)	0.8223
Hypertension		1.04		(0.13,8.52)	0.9683
Coronary Artery Disease		1.33		(0.27,6.51)	0.7215
Congestive Heart Failure		1.63		(0.4,6.61)	0.4977
Hypercholesterolemia		1.10		(0.23,5.4)	0.9026
Renal Failure		1.00		(0.21,4.91)	0.9971
Asymptomatic Indication		0.10		(0.01,0.81)	0.031
TIA Indication		13.69		(1.7,110.47)	0.014
Stroke Indication		1.10		(0.14,9.02)	0.9273
Pre-ProcedureStenosis (70-99 vs 50-69)		0.56		(0.07,4.6)	0.5852
Lesion Length (> 15 mm)		0.96		(0.25,3.62)	0.9501
Pre-dilatation Performed Prior to EPD*		6.09		(1.19,31.2)	0.0303
Pre-dilatation Performed Prior to Stent		1.73		(0.43,7.01)	0.4413
Univariate - Early MI/Stroke/Death
Variable		OR		95% UCL	p-value
Age		1.02		(0.97,1.06)	0.5127
Gender (Male vs Female)		1.00		(0.42,2.38)	0.9913
Hypertension		0.42		(0.15,1.19)	0.101
Coronary Artery Disease		1.01		(0.39,2.65)	0.981
Congestive Heart Failure		0.94		(0.34,2.62)	0.9102
Hypercholesterolemia		0.66		(0.26,1.66)	0.3781
Renal Failure		1.34		(0.51,3.51)	0.5558
Asymptomatic Indication		0.46		(0.19,1.12)	0.0858
TIA Indication		2.04		(0.86,4.82)	0.1055
Stroke Indication		0.88		(0.2,3.87)	0.8603
Pre-procedureStenosis (70-99 vs 50-69)		0.58		(0.13,2.66)	0.4833
Lesion Length (> 15 mm)		0.43		(0.17,1.12)	0.0831
EPD* (ACCUNET vs Other)		0.27		(0.08,0.95)	0.0413
Pre-dilatation Performed Prior to EPD*		2.07		(0.45,9.45)	0.35
Pre-dilatation Performed Prior to Stent		1.03		(0.44,2.43)	0.9463
Post-Stent Dilatation Performed		2.16		(0.63,7.43)	0.2232
Multivariate
Early Stroke
Variable	OR		95% CI			p-value
TIA Indication	15.26		(1.85,125.66)			0.0113
Pre-dilatation Performed Prior to EPD*	7.98		(1.4,45.43)			0.0193
Multivariate
Early MI/Stroke/Death
Variable	OR		95% LCL			p-value
EPD* - ACCUNET vs Other	0.27		(0.08,0.94)			0.0389

* EPD (Embolic Protection Device)